Global Latanoprost Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
119 Pages
"Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness."

Scope of the Report:
This report focuses on the Latanoprost in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Brand Drug
Generic Drug

Market Segment by Applications, can be divided into
Open-angle Glaucoma
Close-angle Glaucoma

There are 15 Chapters to deeply display the global Latanoprost market.

Chapter 1, to describe Latanoprost Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Latanoprost, with sales, revenue, and price of Latanoprost, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Latanoprost, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Latanoprost market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Latanoprost sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview
1.1 Latanoprost Introduction
1.2 Market Analysis by Type
1.2.1 Brand Drug
1.2.2 Generic Drug
1.3 Market Analysis by Applications
1.3.1 Open-angle Glaucoma
1.3.2 Close-angle Glaucoma
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Latanoprost Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Latanoprost Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Latanoprost Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Apotex
2.4.1 Business Overview
2.4.2 Latanoprost Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva
2.5.1 Business Overview
2.5.2 Latanoprost Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Taj Pharma
2.6.1 Business Overview
2.6.2 Latanoprost Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 CR Zizhu
2.7.1 Business Overview
2.7.2 Latanoprost Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Latanoprost Market Competition, by Manufacturer
3.1 Global Latanoprost Sales and Market Share by Manufacturer
3.2 Global Latanoprost Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Latanoprost Manufacturer Market Share
3.3.2 Top 6 Latanoprost Manufacturer Market Share
3.4 Market Competition Trend
4 Global Latanoprost Market Analysis by Regions
4.1 Global Latanoprost Sales, Revenue and Market Share by Regions
4.1.1 Global Latanoprost Sales by Regions (2012-2017)
4.1.2 Global Latanoprost Revenue by Regions (2012-2017)
4.2 North America Latanoprost Sales and Growth (2012-2017)
4.3 Europe Latanoprost Sales and Growth (2012-2017)
4.4 Asia-Pacific Latanoprost Sales and Growth (2012-2017)
4.5 South America Latanoprost Sales and Growth (2012-2017)
4.6 Middle East and Africa Latanoprost Sales and Growth (2012-2017)
5 North America Latanoprost by Countries
5.1 North America Latanoprost Sales, Revenue and Market Share by Countries
5.1.1 North America Latanoprost Sales by Countries (2012-2017)
5.1.2 North America Latanoprost Revenue by Countries (2012-2017)
5.2 USA Latanoprost Sales and Growth (2012-2017)
5.3 Canada Latanoprost Sales and Growth (2012-2017)
5.4 Mexico Latanoprost Sales and Growth (2012-2017)
6 Europe Latanoprost by Countries
6.1 Europe Latanoprost Sales, Revenue and Market Share by Countries
6.1.1 Europe Latanoprost Sales by Countries (2012-2017)
6.1.2 Europe Latanoprost Revenue by Countries (2012-2017)
6.2 Germany Latanoprost Sales and Growth (2012-2017)
6.3 UK Latanoprost Sales and Growth (2012-2017)
6.4 France Latanoprost Sales and Growth (2012-2017)
6.5 Russia Latanoprost Sales and Growth (2012-2017)
6.6 Italy Latanoprost Sales and Growth (2012-2017)
7 Asia-Pacific Latanoprost by Countries
7.1 Asia-Pacific Latanoprost Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Latanoprost Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Latanoprost Revenue by Countries (2012-2017)
7.2 China Latanoprost Sales and Growth (2012-2017)
7.3 Japan Latanoprost Sales and Growth (2012-2017)
7.4 Korea Latanoprost Sales and Growth (2012-2017)
7.5 India Latanoprost Sales and Growth (2012-2017)
7.6 Southeast Asia Latanoprost Sales and Growth (2012-2017)
8 South America Latanoprost by Countries
8.1 South America Latanoprost Sales, Revenue and Market Share by Countries
8.1.1 South America Latanoprost Sales by Countries (2012-2017)
8.1.2 South America Latanoprost Revenue by Countries (2012-2017)
8.2 Brazil Latanoprost Sales and Growth (2012-2017)
8.3 Argentina Latanoprost Sales and Growth (2012-2017)
8.4 Columbia Latanoprost Sales and Growth (2012-2017)
9 Middle East and Africa Latanoprost by Countries
9.1 Middle East and Africa Latanoprost Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Latanoprost Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Latanoprost Revenue by Countries (2012-2017)
9.2 Saudi Arabia Latanoprost Sales and Growth (2012-2017)
9.3 UAE Latanoprost Sales and Growth (2012-2017)
9.4 Egypt Latanoprost Sales and Growth (2012-2017)
9.5 Nigeria Latanoprost Sales and Growth (2012-2017)
9.6 South Africa Latanoprost Sales and Growth (2012-2017)
10 Global Latanoprost Market Segment by Type
10.1 Global Latanoprost Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Latanoprost Sales and Market Share by Type (2012-2017)
10.1.2 Global Latanoprost Revenue and Market Share by Type (2012-2017)
10.2 Brand Drug Sales Growth and Price
10.2.1 Global Brand Drug Sales Growth (2012-2017)
10.2.2 Global Brand Drug Price (2012-2017)
10.3 Generic Drug Sales Growth and Price
10.3.1 Global Generic Drug Sales Growth (2012-2017)
10.3.2 Global Generic Drug Price (2012-2017)
11 Global Latanoprost Market Segment by Application
11.1 Global Latanoprost Sales Market Share by Application (2012-2017)
11.2 Open-angle Glaucoma Sales Growth (2012-2017)
11.3 Close-angle Glaucoma Sales Growth (2012-2017)
12 Latanoprost Market Forecast (2017-2022)
12.1 Global Latanoprost Sales, Revenue and Growth Rate (2017-2022)
12.2 Latanoprost Market Forecast by Regions (2017-2022)
12.2.1 North America Latanoprost Market Forecast (2017-2022)
12.2.2 Europe Latanoprost Market Forecast (2017-2022)
12.2.3 Asia-Pacific Latanoprost Market Forecast (2017-2022)
12.2.4 South America Latanoprost Market Forecast (2017-2022)
12.2.5 Middle East and Africa Latanoprost Market Forecast (2017-2022)
12.3 Latanoprost Market Forecast by Type (2017-2022)
12.4 Latanoprost Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


List of Tables and Figures

Figure Latanoprost Picture
Table Product Specifications of Latanoprost
Figure Global Sales Market Share of Latanoprost by Types in 2016
Table Latanoprost Types for Major Manufacturers
Figure Brand Drug Picture
Figure Generic Drug Picture
Table Latanoprost Sales Market Share by Applications in 2016
Figure Open-angle Glaucoma Picture
Figure Close-angle Glaucoma Picture
Figure USA Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure France Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure UK Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure China Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure India Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Latanoprost Revenue (Value) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Latanoprost Type and Applications
Table Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Latanoprost Type and Applications
Table Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Latanoprost Type and Applications
Table Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Latanoprost Type and Applications
Table Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Latanoprost Type and Applications
Table Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharma Basic Information, Manufacturing Base and Competitors
Table Taj Pharma Latanoprost Type and Applications
Table Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CR Zizhu Basic Information, Manufacturing Base and Competitors
Table CR Zizhu Latanoprost Type and Applications
Table CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Latanoprost Sales by Manufacturer (2016-2017)
Figure Global Latanoprost Sales Market Share by Manufacturer in 2016
Figure Global Latanoprost Sales Market Share by Manufacturer in 2017
Table Global Latanoprost Revenue by Manufacturer (2016-2017)
Figure Global Latanoprost Revenue Market Share by Manufacturer in 2016
Figure Global Latanoprost Revenue Market Share by Manufacturer in 2017
Figure Global Latanoprost Sales and Growth (2012-2017)
Figure Global Latanoprost Revenue and Growth (2012-2017)
Table Global Latanoprost Sales by Regions (2012-2017)
Table Global Latanoprost Sales Market Share by Regions (2012-2017)
Table Global Latanoprost Revenue by Regions (2012-2017)
Table Global Latanoprost Revenue Market Share by Regions in 2012
Table Global Latanoprost Revenue Market Share by Regions in 2016
Figure North America Latanoprost Sales and Growth (2012-2017)
Figure Europe Latanoprost Sales and Growth (2012-2017)
Figure Asia-Pacific Latanoprost Sales and Growth (2012-2017)
Figure South America Latanoprost Sales and Growth (2012-2017)
Figure Middle East and Africa Latanoprost Sales and Growth (2012-2017)
Figure North America Latanoprost Revenue and Growth (2012-2017)
Table North America Latanoprost Sales by Countries (2012-2017)
Table North America Latanoprost Sales Market Share by Countries (2012-2017)
Figure North America Latanoprost Sales Market Share by Countries in 2012
Figure North America Latanoprost Sales Market Share by Countries in 2016
Table North America Latanoprost Revenue by Countries (2012-2017)
Table North America Latanoprost Revenue Market Share by Countries (2012-2017)
Figure North America Latanoprost Revenue Market Share by Countries in 2012
Figure North America Latanoprost Revenue Market Share by Countries in 2016
Figure USA Latanoprost Sales and Growth (2012-2017)
Figure Canada Latanoprost Sales and Growth (2012-2017)
Figure Mexico Latanoprost Sales and Growth (2012-2017)
Figure Europe Latanoprost Revenue and Growth (2012-2017)
Table Europe Latanoprost Sales by Countries (2012-2017)
Table Europe Latanoprost Sales Market Share by Countries (2012-2017)
Table Europe Latanoprost Revenue by Countries (2012-2017)
Table Europe Latanoprost Revenue Market Share by Countries in 2012
Table Europe Latanoprost Revenue Market Share by Countries in 2016
Figure Germany Latanoprost Sales and Growth (2012-2017)
Figure UK Latanoprost Sales and Growth (2012-2017)
Figure France Latanoprost Sales and Growth (2012-2017)
Figure Russia Latanoprost Sales and Growth (2012-2017)
Figure Italy Latanoprost Sales and Growth (2012-2017)
Figure Asia-Pacific Latanoprost Revenue and Growth (2012-2017)
Table Asia-Pacific Latanoprost Sales by Countries (2012-2017)
Table Asia-Pacific Latanoprost Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Latanoprost Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Latanoprost Revenue by Countries (2012-2017)
Table Asia-Pacific Latanoprost Revenue Market Share by Countries (2012-2017)
Figure China Latanoprost Sales and Growth (2012-2017)
Figure Japan Latanoprost Sales and Growth (2012-2017)
Figure Korea Latanoprost Sales and Growth (2012-2017)
Figure India Latanoprost Sales and Growth (2012-2017)
Figure Southeast Asia Latanoprost Sales and Growth (2012-2017)
Figure South America Latanoprost Revenue and Growth (2012-2017)
Table South America Latanoprost Sales by Countries (2012-2017)
Table South America Latanoprost Sales Market Share by Countries (2012-2017)
Figure South America Latanoprost Sales Market Share by Countries in 2016
Table South America Latanoprost Revenue by Countries (2012-2017)
Table South America Latanoprost Revenue Market Share by Countries (2012-2017)
Figure South America Latanoprost Revenue Market Share by Countries in 2012
Figure South America Latanoprost Revenue Market Share by Countries in 2016
Figure Brazil Latanoprost Sales and Growth (2012-2017)
Figure Argentina Latanoprost Sales and Growth (2012-2017)
Figure Columbia Latanoprost Sales and Growth (2012-2017)
Figure Middle East and Africa Latanoprost Revenue and Growth (2012-2017)
Table Middle East and Africa Latanoprost Sales by Countries (2012-2017)
Table Middle East and Africa Latanoprost Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Latanoprost Sales Market Share by Countries in 2016
Table Middle East and Africa Latanoprost Revenue by Countries (2012-2017)
Table Middle East and Africa Latanoprost Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Latanoprost Revenue Market Share by Countries in 2012
Figure Middle East and Africa Latanoprost Revenue Market Share by Countries in 2016
Figure Saudi Arabia Latanoprost Sales and Growth (2012-2017)
Figure UAE Latanoprost Sales and Growth (2012-2017)
Figure Egypt Latanoprost Sales and Growth (2012-2017)
Figure Nigeria Latanoprost Sales and Growth (2012-2017)
Figure South Africa Latanoprost Sales and Growth (2012-2017)
Table Global Latanoprost Sales by Type (2012-2017)
Table Global Latanoprost Sales Share by Type (2012-2017)
Table Global Latanoprost Revenue by Type (2012-2017)
Table Global Latanoprost Revenue Share by Type (2012-2017)
Figure Global Brand Drug Sales Growth (2012-2017)
Figure Global Brand Drug Price (2012-2017)
Figure Global Generic Drug Sales Growth (2012-2017)
Figure Global Generic Drug Price (2012-2017)
Table Global Latanoprost Sales by Application (2012-2017)
Table Global Latanoprost Sales Share by Application (2012-2017)
Figure Global Open-angle Glaucoma Sales Growth (2012-2017)
Figure Global Close-angle Glaucoma Sales Growth (2012-2017)
Figure Global Latanoprost Sales, Revenue and Growth Rate (2017 -2022)
Table Global Latanoprost Sales Forecast by Regions (2017-2022)
Table Global Latanoprost Market Share Forecast by Regions (2017-2022)
Figure North America Sales Latanoprost Market Forecast (2017-2022)
Figure Europe Sales Latanoprost Market Forecast (2017-2022)
Figure Asia-Pacific Sales Latanoprost Market Forecast (2017-2022)
Figure South America Sales Latanoprost Market Forecast (2017-2022)
Figure Middle East and Africa Sales Latanoprost Market Forecast (2017-2022)
Table Global Latanoprost Sales Forecast by Type (2017-2022)
Table Global Latanoprost Market Share Forecast by Type (2017-2022)
Table Global Latanoprost Sales Forecast by Application (2017-2022)
Table Global Latanoprost Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

United States Topical Skin Adhesive Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

"Topical skin adhesive is a wound closure device that is fast, precise and easy to use. Topical ski...Read More

United States Hyaluronic Acid Dermal Filler Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

This report studies the Middle East Hyaluronic Acid Dermal Filler market, Hyaluronic Acid Dermal Fil...Read More

United States Capecitabine Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic br...Read More

Report's License Type

$3480
$4680

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.